A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy-Reference-Cited by-同舟云学术

A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy

Published:2020-10-25 Issue:5 Volume:48 Page:1487-1497
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Paschali A.^ORCID,Panagiotidis E.,Triantafyllou T.,Palaska V.,Tsirou K.,Verrou E.,Υiannaki E.,Markala D.,Papanikolaou A.,Pouli A.,Konstantinidou P.,Chatzipavlidou V.,Terpos E.,Katodritou E.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-020-05078-1.pdf

Reference40 articles.

1. Rajkumar SV. Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management. Am J Hematol. 2018;93:1091–110.

2. Landgren O, Morgan G. Biologic frontiers in multiple myeloma: from biomarker identification to clinical practice. Clin Cancer Res. 2018;20:804–13.

3. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–68.

4. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:538–48.

5. Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, et al. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017;18:206–17.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IMPeTUs parameters correlate with clinical features in newly diagnosed multiple myeloma;European Journal of Radiology Open;2024-12

2. DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach;Cancer Imaging;2024-07-11

3. Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma;EJNMMI Research;2024-05-28

4. Pre-treatment [ ¹⁸ F]FDG PET/CT for assessing bone marrow involvement and prognosis in patients with newly diagnosed peripheral T-cell lymphoma;Hematology;2024-03-11

5. Assessment of diffuse bone marrow involvement on 18F-fluoro-D-glucose PET/computed tomography;Clinical and Translational Imaging;2024-03-04